Fate Therapeutics' GAAP loss for 2021 was $212.151 million, up 22.4% from $173.387 million in the previous year. Revenue increased 77.7% to $55.846 million from $31.434 million a year earlier.
Fate Therapeutics' GAAP loss for 2021 was $212.151 million, up 22.4% from $173.387 million in the previous year. Revenue increased 77.7% to $55.846 million from $31.434 million a year earlier. 
ir.fatetherapeutics.com
English (US) 